Technical Analysis for DXCM - DexCom, Inc.

Grade Last Price % Change Price Change
grade D 129.03 -9.24% -13.13
DXCM closed down 9.24 percent on Friday, March 22, 2019, on 2.92 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical DXCM trend table...

Date Alert Name Type % Chg
Mar 22 MACD Bearish Centerline Cross Bearish 0.00%
Mar 22 Expansion Breakdown Bearish Swing Setup 0.00%
Mar 22 Expansion Pivot Sell Setup Bearish Swing Setup 0.00%
Mar 22 Wide Range Bar Range Expansion 0.00%
Mar 22 Multiple of Ten Bearish Other 0.00%
Mar 22 Below Lower BB Weakness 0.00%
Mar 22 Down 3 Days in a Row Weakness 0.00%
Mar 22 Lower Bollinger Band Touch Weakness 0.00%
Mar 21 Fell Below 20 DMA Bearish -9.24%
Mar 21 Fell Below 50 DMA Bearish -9.24%

Older signals for DXCM ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. The company offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. Its ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments. The company's in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. It also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. The company markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Medical Monitoring Software Platform Endocrinology Blood Glucose Monitoring Continuous Glucose Monitor Hyperglycemia Hypoglycemia
Is DXCM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 156.16
52 Week Low 68.86
Average Volume 1,355,534
200-Day Moving Average 127.6169
50-Day Moving Average 144.6424
20-Day Moving Average 143.261
10-Day Moving Average 144.363
Average True Range 6.2107
ADX 18.77
+DI 19.4094
-DI 29.0798
Chandelier Exit (Long, 3 ATRs ) 137.5279
Chandelier Exit (Short, 3 ATRs ) 146.5321
Upper Bollinger Band 152.0578
Lower Bollinger Band 134.4642
Percent B (%b) -0.31
BandWidth 12.280802
MACD Line -0.5282
MACD Signal Line 0.679
MACD Histogram -1.2072
Fundamentals Value
Market Cap 11.18 Billion
Num Shares 86.6 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -169.78
Price-to-Sales 6.08
Price-to-Book 10.87
PEG Ratio -1.59
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 148.61
Resistance 3 (R3) 150.40 145.68 145.34
Resistance 2 (R2) 145.68 140.69 144.78 144.25
Resistance 1 (R1) 137.35 137.61 134.99 135.56 143.17
Pivot Point 132.63 132.63 131.45 131.73 132.63
Support 1 (S1) 124.30 127.64 121.94 122.51 114.89
Support 2 (S2) 119.58 124.56 118.68 113.81
Support 3 (S3) 111.25 119.58 112.72
Support 4 (S4) 109.46